MELANIE HONEYCUTT: Open Payments
NPI 1033879010 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 16 payments from 12 companies in 2025. Trend: 2023 $416 · 2024 $0 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $178 |
| Gilead Sciences, Inc. | 3 | $138 |
| Ipsen Biopharmaceuticals, Inc | 1 | $111 |
| Celltrion USA Inc. | 2 | $39 |
| Janssen Biotech, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Ardelyx, Inc. | 1 | $19 |
| QOL Medical, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: REZDIFFRA, IQIRVO, Epclusa, VEGZELMA, TREMFYA, DUPIXENT, ZENPEP, IBSRELA.
Industry payments across TN — which companies pay providers there.
